Skip to content

Comparison of Posterior Slab Cast With Total Contact Cast in the Management of Diabetic Foot Ulcers

Comparison of Posterior Slab Cast With Total Contact Cast in the Management of Diabetic Foot Ulcers: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07111741
Enrollment
99
Registered
2025-08-08
Start date
2023-01-04
Completion date
2024-04-10
Last updated
2025-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Foot Ulcer (DFU), Offloading

Brief summary

The goal of this clinical trial is to compare wound healing and foot related outcomes in people with plantar diabetic foot ulcer using Total contact cast (TCC) or Posterior slab cast (PSC). Ninety-nine people with neuropathic DFUs were randomized to use TCC (n=51) or PSC (n=48) together with standard of care for up to 6 months. Researchers will compare rate of healing of ulcer at the end of 6 months, percentage reduction in the surface area, time taken to heal and patient satisfaction. Participants will: * Use TCC or PSC as off-loading till the ulcer heals for upto 6 months * Visit the clinic once every 2 weeks for follow ups when inspection of the wound will be done for wound dressing, wound debridement and infection control when necessary

Interventions

Arm with 51 patients was given total contact cast for offloading DFU

DEVICEPosterior slab cast

Arm with 48 patients were given posterior slab cast for offloading DFU

Sponsors

ILS Hospital, Salt Lake
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* People with diabetes * a single neuropathic plantar DFU * Ulcer belonging to Wagner grade 2 and 3

Exclusion criteria

* Persons with bilateral DFUs * gout * peripheral arterial disease (ABPI \<0.8) * stage 4 and 5 chronic kidney disease \[estimated glomerular filtration rate (eGFR) \<30 ml/min/m2\] * active Charcot arthropathy * history of steroid intake within the past 3 months

Design outcomes

Primary

MeasureTime frameDescription
The primary outcome measure in this study was healing of the ulcer at 6 months.6 monthsWe compared the rate of healing of ulcers and time taken to heal.

Secondary

MeasureTime frameDescription
The secondary outcome measure was the rate of wound size reduction at 4 weeks and patient satisfaction.6 MonthsHealing rates will be measured by the percentage of ulcers healed or wound closure, based on clinical assessment and standardized wound measurement techniques (i.e., wound area reduction). Patient satisfaction was measured using the Likert scale 1-5 (1= very dissatisfied, 5=very satisfied).

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026